Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$498M |
| 2 |
Micron Technology
MU
|
+$374M |
| 3 |
Amazon
AMZN
|
+$356M |
| 4 |
Accenture
ACN
|
+$318M |
| 5 |
Advanced Micro Devices
AMD
|
+$301M |
Top Sells
| 1 |
Apple
AAPL
|
+$684M |
| 2 |
Meta Platforms (Facebook)
META
|
+$630M |
| 3 |
Tesla
TSLA
|
+$595M |
| 4 |
Chevron
CVX
|
+$497M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| 1 | Healthcare | 19.38% |
| 2 | Technology | 18.55% |
| 3 | Consumer Staples | 10.17% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SUP
1826
DELISTED
Superior Industries International
SUP
| $2.72M | ﹤0.01% |
901,409
-44,900
| -5% | -$136K |
|
|
HT
1827
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $2.72M | ﹤0.01% |
341,162
+11,100
| +3% | +$88.6K |
|
1828
Applovin
APP
$212B
| $2.72M | ﹤0.01% |
139,600
-26,600
| -16% | -$518K |
|
1829
Oil States International
OIS
$354M
| $2.71M | ﹤0.01% |
697,586
+248,200
| +55% | +$966K |
|
1830
Innodata
INOD
$2.29B
| $2.71M | ﹤0.01% |
898,490
-119,900
| -12% | -$362K |
|
1831
Paysign
PAYS
$319M
| $2.71M | ﹤0.01% |
1,144,833
-111,399
| -9% | -$264K |
|
|
ALBO
1832
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $2.7M | ﹤0.01% |
139,683
+120,183
| +616% | +$2.33M |
|
1833
BellRing Brands
BRBR
$4.63B
| $2.7M | ﹤0.01% |
+130,987
| New | +$2.7M |
|
1834
First Hawaiian
FHB
$3.22B
| $2.7M | ﹤0.01% |
109,600
-109,300
| -50% | -$2.69M |
|
1835
Turning Point Brands
TPB
$1.86B
| $2.7M | ﹤0.01% |
127,052
-39,745
| -24% | -$844K |
|
1836
iShares MSCI Canada ETF
EWC
$3.3B
| $2.7M | ﹤0.01% |
+87,600
| New | +$2.7M |
|
1837
Equity Bancshares
EQBK
$815M
| $2.69M | ﹤0.01% |
90,800
-6,900
| -7% | -$204K |
|
1838
Lamar Advertising Co
LAMR
$12.7B
| $2.69M | ﹤0.01% |
32,612
-127,300
| -80% | -$10.5M |
|
1839
Gulf Island Fabrication
GIFI
$115M
| $2.69M | ﹤0.01% |
644,924
-35,163
| -5% | -$147K |
|
1840
LeMaitre Vascular
LMAT
$2.1B
| $2.68M | ﹤0.01% |
52,900
-4,100
| -7% | -$208K |
|
1841
Flexsteel Industries
FLXS
$258M
| $2.68M | ﹤0.01% |
170,693
-19,800
| -10% | -$311K |
|
|
BWIN
1842
Baldwin Insurance Group
BWIN
$2.24B
| $2.68M | ﹤0.01% |
101,600
-17,400
| -15% | -$458K |
|
1843
LGL Group
LGL
$35.6M
| $2.67M | ﹤0.01% |
625,419
-2,397
| -0.4% | -$10.2K |
|
1844
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.16B
| $2.66M | ﹤0.01% |
67,900
+24,100
| +55% | +$943K |
|
1845
Quest Resource Holding
QRHC
$32.5M
| $2.65M | ﹤0.01% |
314,392
-86,200
| -22% | -$727K |
|
1846
Innospec
IOSP
$2.05B
| $2.65M | ﹤0.01% |
30,900
+4,400
| +17% | +$377K |
|
1847
Parke Bancorp
PKBK
$265M
| $2.64M | ﹤0.01% |
126,166
-26,768
| -18% | -$561K |
|
1848
Arcos Dorados Holdings
ARCO
$1.42B
| $2.64M | ﹤0.01% |
362,348
+292,170
| +416% | +$2.13M |
|
1849
Insulet
PODD
$23.1B
| $2.64M | ﹤0.01% |
+11,500
| New | +$2.64M |
|
|
CLVS
1850
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.63M | ﹤0.01% |
2,209,700
-78,600
| -3% | -$93.6K |
|